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A review of patients with advanced cervical cancer 
presenting to palliative care services at Queen Elizabeth 
Central Hospital in Blantyre, Malawi 
Abstract
Background
Cervical cancer is the commonest cancer affecting women in Malawi, 
which has the highest rate of  this disease in the world. Most cases are 
diagnosed at an advanced stage .
Aim
To describe the symptom burden, palliative care interventions, and 
outcomes of  cervical cancer patients who entered care at Tiyanjane Clinic 
in Blantyre, Malawi, between January and December 2012. 
Methods
We reviewed the case files of  72 patients presenting to our hospital-based 
palliative care service over one year.
Results
The mean age was 49.5 years. Twenty-six patients (36%) were HIV-
positive and the majority of  these (n = 22; 85%) were on antiretroviral 
medication at presentation to palliative care. Pain (n = 66; 92%), vaginal 
discharge (n = 44; 61%), and unpleasant odour (n = 37; 51%) were 
commonly reported. Over a third of  patients (n = 26; 36%) reported pain 
in two or more sites. Fourteen patients (19%) reported vaginal bleeding. 
Spousal breakdown (through widowhood or divorce) was noted in over 
half  (n = 41; 57%) of  all cases. Pain relief  was provided to 69 (96%) 
of  the patients (morphine to 40 patients; 56%). Common interventions 
provided included metronidazole tablets (used vaginally), sanitary items, 
and counselling. At the end of  the study period, 18 patients (25%) were 
still under the care of  palliative services. 
Conclusions
Access to medications such as morphine, metronidazole and tranexamic 
acid can improve quality of  life, even when radiotherapy is limited. 
Health care teams require necessary skills and training, including how to 
perform a comprehensive assessment, with an emphasis on the provision 
of  psychosexual counselling, to assist with the complexity of  symptoms 
occurring in this vulnerable group.
Introduction
Cancer of  the cervix is the leading cause of  cancer death 
among African women. According to statistics from the 
World Health Organisation (WHO), Malawi has the world’s 
highest age-standardised rate for both incidence (76 per 
100,000) of  cervical cancer and mortality (50 per 100,000) 
from the disease.1 In Africa, for a variety of  reasons, women 
with cancer of  the cervix are often diagnosed late, requiring 
a palliative approach from the time of  presentation. 
Opportunities for screening may be missed,2 and delivery of  
screening services is beset by multiple challenges.3 Invasive 
cancer of  the cervix is categorised as a WHO stage IV AIDS-
defining condition. This means that all women with this 
condition who test positive for HIV qualify automatically 
to start on highly active antiretroviral therapy (HAART), 
irrespective of  CD4 count.4 In Malawi, there is a well-
organised country-wide system for HIV testing and initiation 
of  antiretroviral medication.5 Radiotherapy, a commonly 
utilised treatment modality for the palliative management of  
patients with cancer of  the cervix,6 is not yet available, unless 
patients travel outside the country.
Tiyanjane Clinic started in 2003 and currently runs hospital-
based (inpatient and outpatient) and community-based 
palliative care services from Queen Elizabeth Central 
Hospital (QECH), along with a home-based care service 
from Ndirande Health Centre. Service delivery is integrated 
into the public sector, with supplementary external funding 
utilised to boost capacity. There are currently 10 Tiyanjane 
staff  members: four nurses, three clinicians, and three 
support staff. The team have around 300 patient contacts 
per month. Patients with cancer of  the cervix are referred to 
Tiyanjane Clinic from the gynaecology unit, as well as from 
other sites within and outside the hospital.
The WHO and other international bodies, such as the 
African Palliative Care Association (APCA), have highlighted 
the importance of  palliative care. The literature, however, 
remains sparse on the specifics of  the symptom burden 
and what interventions palliative care services offer in daily 
practise.7 
This study was undertaken in order to describe the symptom 
burden, palliative care interventions, and outcomes of  
cervical cancer patients who entered care at Tiyanjane Clinic 
between January and December 2012. 
Methods
We undertook a retrospective review of  case notes of  new 
patients with cervical cancer who presented between January 
and December 2012. Eligible patients were identified from 
Health Managment Information System (HMIS) records, 
and their Tiyanjane case files were retrieved manually. 
Information concerning demographics (including HIV-
related data) and symptom burden at the time of  their 
initial assessment presentation were collated. Follow-up 
appointment notes were reviewed, with any interventions 
offered, as well as outcome at the last reported follow-up 
(within the study period) recorded. Data were analysed using 
SPSS Version 20. Ethical permission to undertake this study 
was obtained from the University of  Malawi’s College of  
Medicine Research and Ethics Committee (COMREC). 
Results 
Between January and December 2012 Tiyanjane Clinic 
staff  saw a total of  1107 new patients. Eighty-seven (8%) 
had cancer of  the cervix. Of  these, 72 (83%) case files were 
located and included in the analysis.
Age distribution of patients with cancer of the cervix
The ages of  study participants ranged from 20 to 80 years, 
with a mean age of  49.5 years and a modal age of  40 years. 
Social status and HIV infection
Demographic data from this case file review revealed that 
more than half  of  women with cancer of  the cervix did not 
have spouses: 15 (21%) were divorced and 26 (36%) were 
widowed.
Twenty-six (36%) of  the study participants were HIV-positive 
and, of  these, 4 (15%) were not on HAART at the time of  
first presentation to palliative care services. At presentation 
to palliative care services, 17 (24%) of  the patients were of  
uknown HIV status.
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Physical symptom burden 
Pain was the most common presenting symptom, found in 
66 patients (92% ). Over a third (26 patients; 36%) had pain 
in two or more different sites. For the most severe pain felt, 
as reported by the patients, the modal score was 4 (using 
a pain scale of  0-5). Vaginal discharge (44 patients; 61%) 
and unpleasant odour (37 patients; 51%) were commonly 
reported, and 14 patients (19%) reported vaginal bleeding. 
The average number of  symptoms per patient was 4, with a 
range of  1 to 11.
Palliative care interventions 
Pain medication was provided to 69 patients (96%). Forty 
patients (56%) were prescribed morphine. Other drugs 
used included metronidazole for 38 patients (53%) and 
oral tranexamic acid tablets to control vaginal bleeding in 6 
patients (8%). Sanitary pads were provided to 21 (29%) of  
the women. 
After provision of  analgesia, counselling was the next most 
frequently recorded intervention. Sixty-six patients (92%) 
received counselling on disease understanding, 62 (86%) on 
spiritual needs, and 58 (81%) on HIV and sexuality.
Outcomes 
At the end of  one year, 18 patients (25 %) were still under 
review at the palliative care clinic, 24 (33%) of  the patients 
were lost to follow-up, and 8 (11%) were recorded to have 
died during the period under review. Of  the others, 8 (11%) 
moved out of  the district and 5 (7 %) were referred to 
another palliative care unit within the district.
Discussion
This case note review provides an insight into the routine 
palliative care case management of  patients with advanced 
cervical cancer at QECH’s Tiyanjane Clinic in Blantyre, 
Malawi, where access to radiotherapy is limited.
Pain was the most common symptom reported in this case 
file review, as similarly reported in literature from other 
African settings.8 It is recognised that pain is experienced 
throughout the cancer journey, with pain prevalence and 
severity likely to increase as the disease advances. Such pain 
is commonly undertreated, even in settings where a variety 
of  opioids plus alternative approaches to drug management 
of  pain exist. Over half  of  the patients in our case review 
required morphine to manage their pain. This is similar to the 
findings of  Herce et al. in their rapid evaluation of  palliative 
care services established in Neno district in rural Malawi.9 In 
many countries, access to morphine has been a rate-limiting 
step in palliative care expansion. Through partnership and 
sustained advocacy, Malawi is reported to have had some 
success in improving the adequacy of  morphine supply,10 
though prolonged stockouts are still experienced at many 
hospitals across the country (Palliative Care Association 
of  Malawi Drug Advocacy Officer, 2015, personal 
communication). Other medication and supplies, such as 
tranexamic acid and sanitary pads, are not routinely available 
through public health services; Tiyanjane Clinic  purchases 
these items using well-wisher donations. Following WHO 
guidelines, oral metronidazole tablets as vaginal pessaries are 
utilised to reduce the smell of  discharge.11 
Alongside the provision of  symptom control drugs, 
counselling and education were the most commonly 
recorded interventions. Topics that are covered by the team 
include education relating to HIV issues and advice on how 
Figure 1: Age distribution of study patients


























































Married 11 16 4 31
Widowed 12 7 7 26
Divorced 3 6 6 15
Total$ 26 29 17 72
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best to provide appropriate sexual satisfaction to support the 
sexual needs of  the relationship. Disease understanding and 
advanced planning may be explored, guided by the wishes 
of  the patient and their carers. For such concerns to be 
confidently disclosed and discussed, advanced counselling 
skills and an appropriate environment are required.
HIV infection is known to be associated with an increased 
risk of  developing cervical cancer. Our case note review 
recorded that one quarter of  patients were of  unkown 
HIV status at the time of  presentation to our palliative care 
service. However, most of  the patients who were known 
to be HIV-positive (22 patients; 85%) were already taking 
antiretroviral medication. Discussion of  the need for HIV 
testing and provision of  HAART plays a role in palliative 
care consultation in Malawi and similar settings of  high HIV 
prevalence, with care taken to deliver suitable messages to 
the patient and her partner (if  present) about safe sexual 
practises. 
Notably, patients with advanced cancer of  the cervix 
attending palliative care services at QECH had a high rate 
of  loss of  spousal support, with 40 women (56%) in this 
case review either widowed or divorced. Data from national 
surveys (Malawi Demographic Health Survey 2010), in a 
younger population, show that less than 10% of  women 
aged 15 to 49 years are divorced (4.9%) or widowed (3.6%).
It is concerning that our study reports a high loss to follow-
up (24 patients; 33%) during the period under review. Similar 
findings were reported in our earlier published audit of  
inpatient palliative care at QECH.12 In 2012 Tiyanjane Clinic 
had a motorbike and a shared car with which to conduct visits 
to patients’ homes within a 50 km radius from the hospital. 
This capacity is limited. Improving mobile outreach services 
and active case finding of  non-attendees and would enable 
Tiyanjane Clinic to provide care for women even when they 
can no longer manage (either physically or financially) to get 
to the health facility. 
As a retrospective case note review, this study was not able to 
assess the efficacy of  pain medication or other interventions. 
Additionally, the precise detail of  the holistic concerns of  
patients and their families could not be ascertained. Further 
prospective qualitative and quantitative studies are required 
to investigate these important areas. 
Conclusions
This paper reports the common symptoms experienced 
by women with advanced cancer of  the cervix attending 
palliative care services at QECH, the interventions received, 
as well as outcomes.  Palliative care services at QECH 
support patients and families through a significant part of  
their illness journey. Pain is common and frequently severe, 
with over half  of  women requiring oral morphine. Vaginal 
discharge, odour, and bleeding can be managed using safe, 
inexpensive medications and supplies. Loss to follow-up 
from our central teaching hospital palliative care service is 
significant.
Africa is set to see continuing expansion in the numbers of  
patients with cancer, many of  whom are diagnosed once 
their disease is at a late stage. All women with advanced 
cancer of  the cervix need access to HIV testing, and those 
who test HIV-positive require HAART. Health systems must 
provide access to suitable medications such as morphine, 
metronidazole, and tranexamic acid, which can improve 
quality of  life even when access to radiotherapy is limited. 
Health care teams require necessary skills and training, 
including how to perform a comprehensive assessment, with 
an emphasis on the provision psychosexual counselling.
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